Search

Your search keyword '"Tania Bubela"' showing total 145 results

Search Constraints

Start Over You searched for: Author "Tania Bubela" Remove constraint Author: "Tania Bubela"
145 results on '"Tania Bubela"'

Search Results

1. From Patchwork to Framework: Expert Interview Insights on Establishing a Bioethics Council for Canada

2. Asynchronous online focus groups for research with people living with amyotrophic lateral sclerosis and family caregivers: usefulness, acceptability and lessons learned

3. A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada

4. 'I have such a hard time hitting myself, I thought it’d be easier': perspectives of hospitalized patients on injecting drugs into vascular access devices

5. Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis

6. Canadian newspaper coverage on harm reduction featuring bereaved mothers: A mixed methods analysis.

7. Let’s do better: public representations of COVID-19 science

8. Open drug discovery of anti-virals critical for Canada’s pandemic strategy

9. Application of protection motivation theory to clinical trial enrolment for pediatric chronic conditions

10. Social values for health technology assessment in Canada: a scoping review of hepatitis C screening, diagnosis and treatment

11. Conditional Drug Approval as a Path to Market for Oncology Drugs in Canada: Challenges and Recommendations for Assessing Eligibility and Regulatory Responsiveness

12. Communication About End of Life for Patients Living With Amyotrophic Lateral Sclerosis: A Scoping Review of the Empirical Evidence

13. Governance of a global genetic resource commons for non-commercial research: A case-study of the DNA barcode commons

14. Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol [version 2; peer review: 2 approved]

15. Creating a data resource: what will it take to build a medical information commons?

16. Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic

17. Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications

18. The Impact of Heterogeneity in a Global Knowledge Commons: Implications for Governance of the DNA Barcode Commons

19. Canada's Assisted Human Reproduction Act: Pragmatic Reforms in Support of Research

20. Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada

21. Provenance and risk in transfer of biological materials.

22. Reproducibility and Reuse of Adaptive Immune Receptor Repertoire Data

23. More Haste, Less Speed: Could Public–Private Partnerships Advance Cellular Immunotherapies?

24. Experiences in Broker-Facilitated Participatory Cross-Cultural Research

25. Access and benefits sharing of genetic resources and associated traditional knowledge in northern Canada: understanding the legal environment and creating effective research agreements

26. Use and misuse of material transfer agreements: lessons in proportionality from research, repositories, and litigation.

27. Reflections on the cost of 'low-cost' whole genome sequencing: framing the health policy debate.

28. When pictures waste a thousand words: analysis of the 2009 H1N1 pandemic on television news.

29. Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol [version 1; peer review: 1 approved, 1 approved with reservations]

31. The Importance of and Challenges with Adopting Life-Cycle Regulation and Reimbursement in Canada

32. Lessons from Canada’s notice of compliance with conditions policy for the life-cycle regulation of drugs

35. Let’s do better: public representations of COVID-19 science

36. Public Engagement

37. CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS

38. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers

39. Covid-19 threat and coping: application of protection motivation theory to the pandemic experiences of people affected by amyotrophic lateral sclerosis

40. Monitoring progress toward United Nations commitments: characteristics of Canadian legislation to promote tobacco control, physical activity and healthy eating. A descriptive study

41. Importance of Participant-Centricity and Trust for a Sustainable Medical Information Commons

42. ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update

43. Application of Protection Motivation Theory to Clinical Trial Enrolment for Pediatric Chronic Conditions

44. Paving the road to personalized medicine: recommendations on regulatory, intellectual property and reimbursement challenges

45. Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials

46. Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic

47. Participant perspectives on a phase I/II ocular gene therapy trial (NCT02077361)

48. Medical Information Commons to Support Learning Healthcare Systems: Examples From Canada

49. Automated content analysis as a tool for research and practice: a case illustration from the Prairie Creek and Nico environmental assessments in the Northwest Territories, Canada

50. DNA barcoding in the media: does coverage of cool science reflect its social context?

Catalog

Books, media, physical & digital resources